Exosomes in diagnosis and therapy of prostate cancer

Jun Pan; Meng Ding; Kai Xu; Chunhua Yang; Li-Jun Mao

doi:10.18632/oncotarget.18532

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

Exosomes in diagnosis and therapy of prostate cancer

Jun Pan, Meng Ding, Kai Xu, Chunhua Yang and Li-Jun Mao _

PDF | HTML | How to cite

Oncotarget. 2017; 8:97693-97700. https://doi.org/10.18632/oncotarget.18532

Metrics: PDF 3540 views | HTML 7215 views | ?

Abstract

Jun Pan1,*, Meng Ding1,*, Kai Xu1, Chunhua Yang1,2 and Li-Jun Mao1

1Department of Urinary Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China

2Radiotherapy Department, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, China

*These authors contributed equally to this work

Correspondence to:

Li-Jun Mao, email: [email protected]

Chunhua Yang, email: [email protected]

Keywords: prostate cancer, exosome, stromal cells, diagnosis, therapy

Received: January 09, 2017 Accepted: June 02, 2017 Published: June 17, 2017

ABSTRACT

Exosomes are small vesicular bodies released by a variety of cells. Exosomes contain miRNAs, mRNAs and proteins with the potential to regulate signaling pathways in recipient cells. Exosomes deliver nucleic acids and proteins to mediate the communication between cancer cells and stroma cells. In this review, we summarize recent progress in our understanding of the role of exosomes in prostate cancer. The tumorigenesis, metastasis and drug resistance of prostate cancer are associated with the cargos of exosomes such as miRNAs, lncRNAs and proteins. In addition, prostate cancer cells modulate surrounding stromal cells via the exosomes. Affected stromal cells employ the exosomes to modulate microenvironment and promote tumor growth and metastasis. Exosomes derived from prostate cancer cells contribute to cancer chemoresistance. The lipid bilayer membrane of the exosomes makes them promising carriers of drugs and other therapeutic molecules targeting prostate cancer. Furthermore, exosomes can be detected and isolated from various body fluids for the diagnosis of prostate cancer.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 18532

Publication Alerts

Reviews:

Exosomes in diagnosis and therapy of prostate cancer

Abstract